| The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020 | 952 | 2020 |
| B cell epitope spreading: mechanisms and contribution to autoimmune diseases C Cornaby, L Gibbons, V Mayhew, CS Sloan, A Welling, BD Poole Immunology letters 163 (1), 56-68, 2015 | 210 | 2015 |
| Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors M Figueiredo-Braga, C Cornaby, A Cortez, M Bernardes, G Terroso, ... Medicine 97 (28), e11376, 2018 | 156 | 2018 |
| Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters W Li, G Qu, SC Choi, C Cornaby, A Titov, N Kanda, X Teng, H Wang, ... Frontiers in immunology 10, 833, 2019 | 101 | 2019 |
| Sex disparities and neutralizing-antibody durability to SARS-CoV-2 infection in convalescent individuals AJ Markmann, N Giallourou, DR Bhowmik, YJ Hou, A Lerner, DR Martinez, ... Msphere 6 (4), 10.1128/msphere. 00275-21, 2021 | 50 | 2021 |
| Indeterminate QuantiFERON gold plus results reveal deficient interferon gamma responses in severely ill COVID-19 patients JD Ward, C Cornaby, JL Schmitz Journal of Clinical Microbiology 59 (10), 10.1128/jcm. 00811-21, 2021 | 48 | 2021 |
| Influence of biological therapeutics, cytokines, and disease activity on depression in rheumatoid arthritis M Figueiredo-Braga, C Cornaby, A Cortez, M Bernardes, G Terroso, ... Journal of immunology research 2018 (1), 5954897, 2018 | 39 | 2018 |
| Immune cell metabolism in autoimmunity X Teng, W Li, C Cornaby, L Morel Clinical & Experimental Immunology 197 (2), 181-192, 2019 | 36 | 2019 |
| Metabolic regulation of pathogenic autoimmunity: therapeutic targeting X Teng, C Cornaby, W Li, L Morel Current opinion in immunology 61, 10-16, 2019 | 31 | 2019 |
| The RBD of the Spike Protein of SARS-Group Coronaviruses is a highly specific target of SARS-CoV-2 antibodies but not other pathogenic human and animal coronavirus antibodies L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... MedRxiv, 2020.05. 06.20093377, 2020 | 29 | 2020 |
| SARS-CoV-2 seroprevalence among a southern US population indicates limited asymptomatic spread under physical distancing measures A Barzin, JL Schmitz, S Rosin, R Sirpal, M Almond, C Robinette, S Wells, ... MBio 11 (5), 10.1128/mbio. 02426-20, 2020 | 25 | 2020 |
| Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: the role of suffering in chronic autoimmune disease M Figueiredo-Braga, C Cornaby, M Bernardes, M Figueiredo, ... PLoS One 13 (4), e0195579, 2018 | 25 | 2018 |
| Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model J Sharma, TD Collins, T Roach, S Mishra, BK Lam, ZS Mohamed, AE Veal, ... Scientific reports 11 (1), 6354, 2021 | 20 | 2021 |
| Efficacy of the combination of metformin and CTLA4Ig in the (NZB× NZW) F1 mouse model of lupus nephritis C Cornaby, AS Elshikha, X Teng, SC Choi, Y Scindia, A Davidson, ... Immunohorizons 4 (6), 319-331, 2020 | 20 | 2020 |
| T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice W Li, AS Elshikha, C Cornaby, X Teng, G Abboud, J Brown, X Zou, ... JCI insight 5 (11), 2020 | 18 | 2020 |
| Unique molecular identifier-based high-resolution HLA typing and transcript quantitation using long-read sequencing C Cornaby, MC Montgomery, C Liu, ET Weimer Frontiers in Genetics 13, 901377, 2022 | 17 | 2022 |
| The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies JD Ward, C Cornaby, T Kato, RC Gilmore, D Bunch, MB Miller, ... Placenta 123, 12-23, 2022 | 15 | 2022 |
| The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients, Sci. Immunol. 5 (2020) L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... | 15 | |
| Outcomes of convalescent plasma with defined high versus lower neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma … LA Bartelt, AJ Markmann, B Nelson, J Keys, H Root, HI Henderson, ... MBio 13 (5), e01751-22, 2022 | 13 | 2022 |
| Next-generation sequencing and clinical histocompatibility testing C Cornaby, JL Schmitz, ET Weimer Human Immunology 82 (11), 829-837, 2021 | 12 | 2021 |
John SchmitzProfessor of Pathology & Laboratory Medicine, UNC Chapel HillVerified email at unchealth.unc.edu
